John L Lamattina Ligand Pharmaceuticals Inc (LGND) insider trading activity

John L Lamattina is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 29,515 shares of LGND, which is worth approximately $3.36 Million. The most recent transaction as insider was on Nov 27, 2024, when has been sold 2,406 shares (Common Stock) at a price of $123.65 per share, resulting in proceeds of $297,501. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.5K

0% 3M change

4.43% 12M change

Total Value Held $3.36 Million

JOHN L LAMATTINA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 27 2024	SELL Open market or private sale	$297,501 $123.65 p/Share	2,406 Reduced 7.54%	29,515 Common Stock
Nov 27 2024	BUY Exercise of conversion of derivative security	$125,833 $52.3 p/Share	2,406 Added 7.01%	31,921 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	1,252 Added 4.07%	29,515 Common Stock
Jun 09 2023	BUY Grant, award, or other acquisition	-	1,142 Added 3.88%	28,263 Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	1,004 Added 3.66%	26,402 Common Stock
Nov 16 2021	SELL Open market or private sale	$782,593 $161.86 p/Share	4,835 Reduced 15.99%	25,398 Common Stock
Nov 16 2021	BUY Exercise of conversion of derivative security	$156,170 $32.3 p/Share	4,835 Added 13.79%	30,233 Common Stock
Jun 04 2021	BUY Grant, award, or other acquisition	-	630 Added 2.42%	25,398 Common Stock

Also insider at

IMNM

Immunome Inc. Healthcare

Director

JLL

John L Lamattina

Director

Emeryville, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Value

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

Operation

Value

Type

News

Receive news related to LIGAND PHARMACEUTICALS INC

Track Activities on LGND

Account